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ARTICLE

Ozone exposure in a mouse model induces
airway hyperreactivity that requires the
presence of natural killer T cells and IL-17
Muriel Pichavant,1 Sho Goya,1 Everett H. Meyer,1,5 Richard A. Johnston,2
Hye Y. Kim,1 Ponpan Matangkasombut,1 Ming Zhu,2 Yoichiro Iwakura,3
Paul B. Savage,4 Rosemarie H. DeKruyff,1 Stephanie A. Shore,2
and Dale T. Umetsu1
1Children’s

Hospital Boston, Harvard Medical School, Boston, MA 02115
School of Public Health, Boston, MA 02115
3Center for Experimental Medicine, The Institute of Medical Science, The University of Tokyo,
Minato-ku, Tokyo 108-8639, Japan
4Brigham Young University, Provo, UT 84604
5Stanford Immunology Program, Stanford University, Stanford, CA 94305

Exposure to ozone, which is a major component of air pollution, induces a form of asthma
that occurs in the absence of adaptive immunity. Although ozone-induced asthma is characterized by airway neutrophilia, and not eosinophilia, it is nevertheless associated with
airway hyperreactivity (AHR), which is a cardinal feature of asthma. Because AHR induced
by allergens requires the presence of natural killer T (NKT) cells, we asked whether ozoneinduced AHR had similar requirements. We found that repeated exposure of wild-type (WT)
mice to ozone induced severe AHR associated with an increase in airway NKT cells, neutrophils, and macrophages. Surprisingly, NKT cell–deficient (CD1d/ and J18/) mice failed
to develop ozone-induced AHR. Further, treatment of WT mice with an anti-CD1d mAb
blocked NKT cell activation and prevented ozone-induced AHR. Moreover, ozone-induced,
but not allergen-induced, AHR was associated with NKT cells producing interleukin (IL)-17,
and failed to occur in IL-17/ mice nor in WT mice treated with anti–IL-17 mAb. Thus,
ozone exposure induces AHR that requires the presence of NKT cells and IL-17 production.
Because NKT cells are required for the development of two very disparate forms of AHR
(ozone- and allergen-induced), our results strongly suggest that NKT cells mediate a unifying
pathogenic mechanism for several distinct forms of asthma, and represent a unique target
for effective asthma therapy.

CORRESPONDENCE
Dale T. Umetsu:
dale.umetsu@
childrens.harvard.edu
Abbreviations used: ␣-GalCer,
␣-galactosylceramide; AHR,
airway hyperreactivity; ppm,
parts per million.

Bronchial asthma is a heterogeneous syndrome
associated with diverse factors, including allergen sensitization, infection, obesity, as well
as exposure to air pollution (1). Regardless of
the trigger, asthma is associated with reversible
airway obstruction and airway hyperreactivity
(AHR) and an increased sensitivity of the airways to nonspecific stimuli such as cold air or
respiratory irritants, and quantitated by responsiveness to methacholine or histamine (2). Diverse mechanisms have been proposed to explain
the pathogenesis of various asthma phenotypes,
including allergic inflammation, Th2 cells, eosinophils, basophils (3), neutrophils (4), and oxidative stress (5). Thus, different forms of asthma
The online version of this article contains supplemental material.
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appear to depend on distinct cell types and pathways, and a shared disease mechanism for all
forms of asthma has not been established.
Invariant TCR natural killer T (iNKT) cells
comprise a newly described, unique subset of
lymphocytes that express features of both classical
T cells and NK cells. iNKT cells express a conserved/invariant TCR repertoire consisting of
V␣14-J␣18 (in mice) or V␣24-J␣18 (in humans)
(6). iNKT cells are activated by recognition of
glycolipid antigens presented by the nonpolymorphic MHC class I–like protein CD1d, which
is widely expressed by airway and intestinal epithelial cells, B cells, macrophages, and dendritic
cells. Recognition of CD1d-presented glycolipids by iNKT cells is highly conserved across phylogeny, suggesting that iNKT cells play a pivotal
385
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RESULTS
NKT cells are required for AHR induced by repeated
ozone exposure
We exposed mice to ozone (1 part per million [ppm] for 3 h)
every other day over a 5-d period, using a semiacute protocol
386

that maximized airway inflammatory cell recruitment over a
brief period of time. Exposure of WT BALB/c mice to ozone
in this manner resulted in higher baseline airway resistance,
and in the development of severe AHR (Fig. 1 A) and significant airway inflammation, consisting of increased macrophages, lymphocytes, and neutrophils, but not eosinophils, in
the bronchoalveolar lavage (BAL) fluid (Fig. 1 C). Repeated
ozone exposure also increased the number of iNKT cells in
the BAL fluid by >10-fold (Fig. 1 D, and Fig. S1, available
at http://www.jem.org/cgi/content/full/jem.20071507/DC1).
To determine the role of these iNKT cells in the development of AHR, we compared WT mice and CD1d⫺/⫺ mice,
which lack the restriction element of NKT cells, and therefore lack NKT cells (6). Surprisingly, CD1d⫺/⫺ mice exposed
to ozone failed to develop AHR (Fig. 1 A). The CD1d⫺/⫺
mice exposed to repeated ozone exposure also had fewer
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role in immunity (7, 8). Activation of iNKT cells results in an
innate-like immune response, with rapid production of large
quantities of cytokines, including IL-4 and IFN-␥ (6, 9), and
this rapid response endows iNKT cells with the capacity to critically amplify adaptive immunity and regulate the development
of polarized T cells. The rapid production of cytokines by
iNKT cells has been shown to regulate the development of
several diseases, including diabetes mellitus, colitis, autoimmune
neurological disease, rejection of malignant tumors, infectious
diseases, and asthma (10–14).
In animal models of allergic asthma, iNKT cell–deficient
mice (CD1d⫺/⫺ or J␣18⫺/⫺ mice) fail to develop AHR when
sensitized and challenged with allergens (13, 14). This requirement for iNKT cells in the development of allergen-induced
AHR is independent of Th2 responses, which develop normally
in these mice (15). The requirement for iNKT cells is also specific because adoptive transfer of WT iNKT cells reconstituted
the capacity of J␣18⫺/⫺ mice to develop AHR. Furthermore,
direct activation of iNKT cells by the respiratory administration
of glycolipids such as ␣-Galactosylceramide (␣-GalCer) or
glycolipids isolated from Sphingomonas bacteria caused AHR and
airway inflammation, even in the complete absence of class II
MHC–restricted T cells and adaptive immunity (16). Moreover, iNKT cells are present in the lungs of patients with asthma
(17–19), although the specific factors that regulate their frequency and function in the lungs has not been fully established.
Together, these studies suggest that iNKT cells play a very important role in the development of asthma and AHR.
To determine whether iNKT cells form the basis for a
shared pathogenic mechanism for different forms of asthma,
we examined the role of iNKT cells in a form of AHR not
thought to involve immune mechanisms, i.e., that induced
by exposure to ozone, a major component of air pollution.
In children, ambient exposure to ozone increases asthmatic
symptoms even at concentrations below the U.S. Environmental Protection Agency standard (20), and hospital admissions for asthma are higher on days of high ambient ozone
concentrations (21, 22). Even in healthy individuals, exposure to ozone induces the development of AHR that is associated with airway epithelial cell damage and an increase in
neutrophils and inflammatory mediators (TNF-␣, CXCL-8/
IL-8, IL-6, and GM-CSF) in proximal airways (23, 24), and
asthmatics appear to be more susceptible to the adverse effects
of this pollutant (25). In our current studies, we demonstrated
that repeated exposure of mice to ozone induced AHR that
required the presence of iNKT cells and the production of
IL-17, which is a potent neutrophil chemotactic factor. These
results suggest that innate immunity involving iNKT cells
may play a critical role as a unifying pathogenic mechanism
for several very distinct forms of asthma.

Figure 1. Ozone exposure induces AHR and increases airway
inflammation in WT, but not in CD1d/, mice. WT BALB/c mice and
NKT cell–deficient CD1d⫺/⫺ mice were exposed 3 times to 1 ppm of ozone
over 5 d or to room air. (A) Changes in lung resistance (RL) were measured
in anesthetized, tracheotomized, intubated, and mechanically ventilated
mice. Ozone exposure induces an increase in AHR in WT, but not in
CD1d⫺/⫺, mice. (B) WT BALB/c and CD1d⫺/⫺ mice were exposed to ozone
as in A, and treated with anti-CD1d blocking mAb or isotype control mAb.
Ozone-induced AHR was prevented by the anti-CD1d mAb treatment.
(C) BAL fluid was collected 24 h after the last ozone challenge of mice
depicted in A and B. Total and differential cell counts were evaluated in
BAL fluid. Ozone exposure induced pulmonary inflammation associated
with neutrophils, which was reduced by treatment with anti-CD1d mAb
and in CD1d⫺/⫺ mice. The inset is a magnification of the data for lymphocytes and neutrophils. (D) Ozone exposure increased the number of iNKT
cells in BAL fluid of WT, but not CD1d⫺/⫺, mice. Anti-CD1d mAb treatment
decreased the number of iNKT cells in BAL fluid after ozone exposure.
iNKT cells were identified by staining with CD1d tetramers loaded with
PBS57 (or with empty CD1d tetramers as control) and anti-TCR␤ mAb.
Results are expressed as the mean ± the SEM. P ≤ 0.05 (*) and P ≤ 0.01 (**)
compared with mice exposed to air. These results represent one out of
four experiments, with five mice in each group.
OZONE-INDUCED AHR REQUIRES NKT CELLS AND IL-17 | Pichavant et al.
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airway macrophages, and significantly less airway lymphocytes and neutrophils in BAL fluid compared with that of
WT mice (Fig. 1 C). The requirement for iNKT cells was
not dependent on the genetic background of our mice (all
backcrossed to BALB/c), as we observed the same effects
in C57BL/6 mice (unpublished data). Pretreatment of WT
mice with an anti-CD1d–blocking mAb to prevent iNKT
cell activation also reduced ozone-induced AHR (Fig. 1 B),
and decreased the number of lymphocytes, neutrophils, and
iNKT cell numbers in the BAL fluid (Fig. 1, C and D). Thus,
repeated exposure of mice to ozone induced AHR that depended on the presence of CD1d restricted T cells.

IL-17 is required for ozone-induced neutrophilia and AHR
Because ozone-induced AHR was associated with airway
neutrophilia, we evaluated the role of IL-17, which has been
shown to enhance neutrophil migration to sites of inflammation (26, 27). We found that repeated ozone exposure was
associated with the induction of IL-17 synthesis in iNKT
cells and small numbers of T cells in the lungs (Fig. 3 A), but
not in the spleen (not depicted). Note that the total number
of cells in the lungs was greatly increased after ozone treatment (three- to sixfold), and therefore the percentages of cells
indicated by flow cytometry underestimated the increases in
IL-17–producing cells induced with ozone exposure. In addition, we found that the pulmonary iNKT cells produced
IL-4, but not IFN-␥, unlike resting or activated splenic iNKT
cells, which produce both IL-4 and IFN-␥, suggesting that
IL-4, but not IFN-␥, production by iNKT cells also played a
role in the induction of ozone AHR. Ozone also induced
IL-10 expression in iNKT cells, but not T cells, in the lungs
(Fig. 3 A). To assess expression of NK1.1 by the iNKT cells
(not present in BALB/c mice), we exposed C57BL/6 mice
JEM VOL. 205, February 18, 2008

Figure 2. Ozone exposure induces AHR in WT, but not in J18/,
mice. WT BALB/c and iNKT cell–deficient J␣18⫺/⫺ mice were exposed
3 times to 1 ppm of ozone versus air. (A) Changes in lung resistance (RL)
were measured on anesthetized, tracheotomized, intubated, and mechanically ventilated mice. Ozone exposure induced significant AHR in WT, but
not in J␣18⫺/⫺ mice. (B) Total and differential cell counts in BAL fluid
were evaluated. WT, but not J␣18⫺/⫺, mice develop an increase in the
number of airway macrophages, lymphocytes, and neutrophils. The insert
is a magnification of the data for lymphocytes and neutrophils. (C) Ozone
exposure increases iNKT cell number in BAL fluid of WT, but not J␣18⫺/⫺,
mice. NKT cells were identified as described in Fig. 1 D. (D) Adoptive transfer
of WT iNKT cells into J␣18⫺/⫺ mice partially restores AHR induced by
repeated ozone exposure. Results are expressed as the mean ± the SEM.
P ≤ 0.05 (*) and P ≤ 0.01 (**) compared with mice exposed to air. These results represent one out of four experiments, with five mice in each group.

to ozone and found that the IL-17–producing T cells were
NK1.1⫺ (Fig. 3 C). This suggests that the IL-17–producing
iNKT cells induced with ozone were distinct from the IL-4/
IL-13–producing iNKT cells, which are generally NK1.1+,
at least in C57BL/6 mice.
To determine whether the development of ozone-induced
AHR required IL-17 production by conventional CD4+
T cells (Th17 cells) or by iNKT cells, we exposed MHC class
II⫺/⫺ mice, which lack conventional CD4+ T cells but have
iNKT cells, to ozone. Fig. 3 B shows that the MHC class
II⫺/⫺ mice developed severe ozone-induced AHR and severe airway inflammation (not depicted), as did the WT mice
exposed to ozone. These results clearly indicated that IL-17–
producing iNKT cells and not Th17 cells are required for
the development of ozone-induced AHR, although it is
possible that Th17 cells may contribute to the development
of AHR.
Ozone-induced, but not allergen-induced, AHR
requires IL-17
Importantly, IL-17 production in the lungs was absolutely
required for ozone-induced AHR because treatment of mice
387
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J18/ mice fail to develop ozone-induced AHR
To confirm that iNKT cells were specifically required for the
development of ozone-induced AHR, we examined another
iNKT cell–deficient strain, J␣18⫺/⫺ mice, which lack the invariant TCR-␣ chain, and therefore lack iNKT cells (6).
Like CD1d⫺/⫺ mice, J␣18⫺/⫺ mice repeatedly exposed to
ozone over 5 d failed to develop AHR, whereas WT mice
exposed to ozone developed severe AHR (Fig. 2 A). Compared with WT mice, J␣18⫺/⫺ mice exposed to ozone also
had significantly reduced numbers of airway macrophages,
lymphocytes, and neutrophils (Fig. 2 B) and no detectable
iNKT cells (Fig. 2 C) in BAL fluid. The specific requirement
for iNKT cells in the development of ozone-induced AHR
was demonstrated by adoptive transfer of purified WT iNKT
cells into J␣18⫺/⫺ mice, which partially restored the capacity
of J␣18⫺/⫺ mice to develop ozone-induced AHR (Fig. 2 D).
Full restoration of the AHR response was not achieved by
adoptive transfer of WT iNKT cells, presumably because insufficient numbers of iNKT cells migrated into the lungs of
recipients (the number of iNKT cells in the BAL fluid of recipients was only 30% of that found in WT mice; unpublished data).
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with an anti–IL-17 blocking mAb greatly reduced ozoneinduced AHR (Fig. 4 A), airway lymphocytes, and neutrophils (but not macrophages; Fig. 4 B). These results were
confirmed in IL-17⫺/⫺ mice, which failed to develop ozoneinduced AHR (Fig. 4 E) and inflammation (Fig. S2, available
at http://www.jem.org/cgi/content/full/jem.20071507/DC1).
IL-17 production by iNKT cells or T cells was required specifically for ozone-induced, but not allergen-induced, AHR
because OVA-induced AHR and inflammation occurred
normally in WT mice treated with anti–IL-17 blocking mAb
(Figs. 4, C and D) and in IL-17⫺/⫺ mice (Fig. 4 F). In addition, IL-17–producing cells were not detected in the lungs
of mice sensitized and challenged with OVA to induce AHR
(unpublished data). Therefore, these results demonstrate
that IL-17 plays a critical role in the development of AHR
and airway inflammation induced by repeated ozone exposure, but not by allergen. Thus, although both allergen- and
ozone-induced AHR require the presence of iNKT cells,
388

the cytokines produced by these cells are distinct, with IL-17
playing a pathogenic role in ozone-induced, but not allergeninduced AHR.
IL-4 and -13 are also involved in ozone-induced AHR
and airway inflammation
We previously showed that iNKT cells producing IL-4 and
-13 are essential in the development of allergen-induced
AHR (13). Because IL-4 was present in most of the iNKT
cells in the lungs of ozone-exposed mice (Fig. 3), we sought
to determine whether IL-4 and -13 were also required for
AHR induced by repeated ozone exposure. To that end, we
exposed IL-4⫺/⫺/IL-13⫺/⫺ double knockout, IL-13⫺/⫺, and
IL-4⫺/⫺ mice to ozone over a 5-d period. After exposure to
ozone, the IL-4⫺/⫺/IL-13⫺/⫺ mice failed to develop AHR
and had reduced airway inflammation, including significantly
fewer macrophages and lymphocytes, compared with WT
mice (Figs. 5, A and B). The requirement of IL-4 and -13
OZONE-INDUCED AHR REQUIRES NKT CELLS AND IL-17 | Pichavant et al.
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Figure 3. iNKT cells and T cells produce IL-17 after ozone exposure. WT BALB/c mice were exposed 3 times to 1 ppm of ozone versus air. Intracellular IL-4, IFN-␥, IL-17, and IL-10 staining was performed on T cell–enriched lung cells without further stimulation, but treated with GolgiStop for 2 h.
(A) iNKT cells were analyzed by gating on CD1d tetramer+ TCR␤+ cells (top). T cells were analyzed by gating on CD1d tetramer⫺ cells (bottom). The flow
cytometry data are provided as dot plots. Numbers in each quadrant indicate the percentage of cells in that quadrant. The number of dots (events) is
much greater for T cells than for iNKT cells because the number of NKT cells in the lungs is only a fraction of the number of T cells present. Data are
representative of three independent experiments. (B) MHC class II⫺/⫺ mice were exposed to ozone or air. Changes in lung resistance (RL) were measured
on anesthetized, tracheotomized, intubated, and mechanically ventilated mice. Ozone exposure induced significant AHR in WT mice and MHC class II⫺/⫺
mice. (C) C57BL/6 mice were exposed to ozone. iNKT cells in the BAL fluid were analyzed by gating on CD1d tetramer+ TCR␤+ cells, and by staining for
expression of NK1.1 and IL-17. The IL-17+ cells were NK1.1 negative.
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production by iNKT cells for ozone-induced AHR was confirmed by additional studies demonstrating that adoptive
transfer of iNKT cells purified from IL-4⫺/⫺/IL-13⫺/⫺ double knockout mice into J␣18⫺/⫺ mice failed to reconstitute
ozone-induced AHR (Fig. 5 C), whereas transfer of WT
iNKT cells partially restored AHR (Fig. 2 D). Furthermore,
IL-13⫺/⫺ and -4⫺/⫺ mice exposed to ozone both failed to
develop AHR (Figs. 5, D and E, and Fig. S2). These results
indicate that although allergen- and ozone-induced AHR
JEM VOL. 205, February 18, 2008

Figure 5. IL-4 and -13 are involved in ozone-induced AHR and
airway inflammation. WT BALB/c, IL-4⫺/⫺/IL-13⫺/⫺ double-knockout,
IL-13⫺/⫺, and IL-4⫺/⫺ mice were exposed 3 times to 1 ppm of ozone versus
air. (A) AHR was measured as in Fig. 4 A. IL-4⫺/⫺/IL-13⫺/⫺ double-knockout mice failed to develop ozone-induced AHR. (B) Total and differential
cell counts were evaluated in BAL fluid. IL-4⫺/⫺/IL-13⫺/⫺ double-knockout
mice failed to develop ozone-induced airway inflammation. (C) Adoptive
transfer of IL-4⫺/⫺/IL-13⫺/⫺ iNKT cells into J␣18⫺/⫺ failed to restore
ozone-induced AHR. Results are expressed as the mean ± the SEM.
P ≤ 0.05 (*) and P ≤ 0.01 (**) compared with mice exposed to air, and doubleknockout mice. These results are representative of three experiments.
(D) IL-13⫺/⫺ mice were exposed to ozone before measurement of AHR, as
in A. AHR failed to occur in the IL-13⫺/⫺ mice. (E) IL-4⫺/⫺ mice were exposed
to ozone before measurement of AHR, as in A. AHR failed to occur in the
IL-4⫺/⫺ mice.

differ in their requirement for IL-17 and in the types of inflammatory cells present in the airways (eosinophils versus
neutrophils), both forms of AHR require iNKT cells producing IL-4 and -13.
DISCUSSION
In this study, we demonstrated that repeated exposure to
ozone induces AHR mediated by a novel mechanism involving innate-like immunity, iNKT cells, and IL-17. Thus,
iNKT cell–deficient mice, including CD1d⫺/⫺ and J␣18⫺/⫺
strains, generated by disruption of two completely independent genes failed to develop ozone-induced AHR. Blockade
389
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Figure 4. IL-17 is involved in ozone-induced, but not in OVAinduced, AHR. (A and B) The response of WT mice to ozone was greatly
reduced by treatment with anti–IL-17 mAb (aIL-17 Ab). WT mice were
exposed 3 times to 1 ppm ozone versus air and treated with anti–IL-17
blocking mAb or isotype control. (A) Airway responsiveness to methacholine was measured in anesthetized, tracheotomized, intubated, and
mechanically ventilated mice and reported as the percentage of increase in airway resistance. (B) BAL fluid was collected 24 h after the
last airway challenge. Total and differential cell counts were evaluated.
Treatment with anti–IL-17 reduced airway lymphocytes and neutrophils.
(C and D) Anti–IL-17 Ab treatment does not reduce OVA-induced AHR (C)
or OVA-induced airway inflammation (D). Mice were sensitized i.p. and
challenged intranasally with OVA for 3 d, and were treated with anti–IL-17
blocking mAb or isotype control 1 d before the 3 OVA challenges. (D) BAL
fluid was collected and evaluated as in B. Results are expressed as the
mean ± the SEM. P ≤ 0.05 (*) and P ≤ 0.01 (**) compared with untreated mice
or mice exposed to air. Data are representative of two independent experiments with five mice in each group. (E) IL-17⫺/⫺ mice fail to develop ozoneinduced AHR. Mice were treated as in A and B, and examined for AHR.
(F) IL-17⫺/⫺ mice develop normal OVA-induced AHR. IL-17⫺/⫺ mice were
sensitized and challenged with OVA before examination for AHR by
challenge with methacholine.
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form of AHR was characterized by the presence of eosinophils and with high levels of IL-4 and -13 (13). These differences may reflect the fact that the cytokine profile of the
iNKT cells involved in these two different forms of AHR is
distinct, with iNKT cells in allergen-induced AHR producing IL-4, but not IL-17, and iNKT cells in ozone-induced
AHR producing IL-17 and -4 (Fig. 3) and not expressing
NK1.1 (when performed in C57BL/6 mice). Indeed, IL-17
production by iNKT cells appears to be critical for ozoneinduced, but not allergen-induced, AHR because IL-17⫺/⫺
mice and WT mice treated with anti–IL-17 mAb failed to
develop ozone-induced, but not allergen-induced AHR.
Moreover, MHC class II⫺/⫺ mice developed ozone-induced
AHR, indicating that IL-17–producing iNKT cells and not
class II MHC–restricted Th17 cells, which have been shown
to critically regulate the development of autoimmune disease
(36), are required for the development of ozone-induced
AHR. Recently, respiratory exposure to ␣-GalCer has been
shown to induce IL-17 production by pulmonary NK1.1⫺
iNKT cells, associated with airway neutrophils, suggesting
that IL-17 production by iNKT cells can occur in some circumstances, although the specific function of these IL-17–
producing NK1.1⫺ iNKT cells in terms of AHR was not
clear (37).
Previous studies have provided conflicting results regarding the role of IL-17 in asthma. IL-17 is known to play an
important role in activating T cells (38), enhancing neutrophil accumulation, and inducing IL-6, TNF-␣, and TGF-␤
production, which increase airway inflammation (39). Although IL-17 (protein and mRNA) is present in the lungs of
patients with severe asthma, along with eosinophils and neutrophils (40–42), or in the lungs of mice chronically exposed
to OVA (43), other studies have indicated that IL-17 has a
potent inhibitory role (44), or that it has minimal effects (38),
on allergen-induced AHR. Our results help to resolve these
discrepancies, and suggest that IL-17 production by iNKT
cells (and possibly by Th17 cells) mediates and is required for
a specific form of AHR (i.e., ozone-induced AHR associated
with airway neutrophilia), but may have a minor role in other
forms of AHR (i.e., allergen-induced AHR, associated primarily with Th2-driven eosinophilic inflammation) (44).
However, it is possible that under some circumstances, when
adaptive allergen-specific Th2 responses develop in the context of oxidative stress and/or exposure to ozone in a single
individual, both IL-4– and IL-17–producing iNKT cells may
be present to synergistically drive the development of lung
inflammation and AHR. This is consistent with the observation that exposure to air pollution and allergens together results in severe airway inflammation and asthma (45, 46).
The idea that ozone exposure leads to the activation of
iNKT cells and to the development of AHR may be related
to the observation that iNKT cells can exacerbate atherosclerotic heart disease (47). These observations together suggest
that ozone exposure alters/oxidizes lipids that are sensed by
iNKT cells, which then initiate the inflammation leading to
the development of asthma or atherosclerotic heart disease.
OZONE-INDUCED AHR REQUIRES NKT CELLS AND IL-17 | Pichavant et al.
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of iNKT cell activation with an anti-CD1d mAb also prevented ozone-induced AHR and the recruitment of iNKT
cells into the lungs. Furthermore, ozone-induced AHR was
associated with IL-17 production by pulmonary iNKT, and
neutralization of IL-17 with anti–IL-17 mAb or by disruption of the IL-17 gene prevented the development of ozoneinduced, but not allergen-induced, AHR. Together, these
results demonstrate for the first time that repeated exposure
to ozone induces the development of AHR in a process that
requires iNKT cells (presumably responding to oxidized selflipids), as well as IL-17, but not adaptive immunity, conventional Th2 cells, or eosinophils.
Although respiratory exposure to ozone is known to trigger clinical symptoms of asthma and to induce toxic responses
that have been studied extensively in laboratory animals and
humans, the precise mechanisms by which ozone causes
asthma have not been fully defined. We and others have
shown previously that a single acute exposure to ozone (2
ppm for 3 h) results in the pulmonary expression of proinflammatory cytokines, including TNF-␣, IL-6, and IL-1,
which play important roles in the airway inflammation and/
or AHR induced by such ozone exposures (28–32). Although
in our current studies we used repeated ozone exposure to
maximize airway inflammation and iNKT cell recruitment
over a brief period of time and have not yet compared our
current model with the single acute exposure model, it is
conceivable that these acute phase cytokines lead to the production of chemokines that recruit iNKT cells, which then
induce AHR upon subsequent ozone exposure. It is also
known that exposure to ozone induces the generation of reactive oxygen species, hydrogen peroxide, and aldehydes
(from the ozonation of unsaturated fatty acids), leading to
oxidative stress responses (33). As such, polymorphisms in the
genes that regulate intracellular levels of the antioxidant
glutathione (GSTM1 and GSTP1) are associated with an
increased susceptibility to respiratory symptoms related to
ozone exposure in asthmatic children (34). Disruption of the
nuclear erythroid 2 p45-related factor 2 (Nrf 2) gene, which
transcriptionally regulates many antioxidant genes, also leads
to severe allergen-driven airway inflammation and AHR
(35), which is consistent with the observation that exposure
to ozone and to ultrafine particulates in air pollution increases
airway inflammation and potentiates immune responses to
inhaled allergens (5). Thus, oxidative stress appears to play a
role in the airway responses to both allergy and ozone. We
now suggest that asthma associated with air pollution/oxidative
stress shares another very important pathogenic disease mechanism with allergen-induced asthma, i.e., AHR that requires
the presence of iNKT cells.
Although our data indicate that iNKT cells are required
for both allergen-induced (13) and ozone-induced AHR
(Fig. 1 A and Fig. 2 A), the pulmonary inflammation induced
by ozone exposure is very distinct from that induced by allergen. In our mouse model, ozone-induced AHR was characterized by the presence of neutrophils, IL-17, and a small
number of cells expressing IL-4, whereas the allergen-induced
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MATERIALS AND METHODS
Mice. Wild-type BALB/c ByJ and C57BL/6N mice were purchased from
The Jackson Laboratory. CD1d⫺/⫺ and J␣18⫺/⫺ mice (both backcrossed to
BALB/c) were gifts from M. Grusby (Harvard School of Public Health,
Boston, MA) (50) and M. Taniguchi and T. Nakayama (Chiba University,
Chiba, Japan) (51), respectively. IL-17⫺/⫺ mice on the C57BL/6 background were generated as previously described (38), and were bred in our
mouse colony. IL-13⫺/⫺ and IL-4⫺/⫺/IL-13⫺/⫺ double-knockout mice
(BALB/c background) were obtained from A. McKenzie (Medical Research
Council Laboratory of Molecular Biology, Cambridge, UK). IL-4⫺/⫺ and
MHC class II⫺/⫺ mice were obtained from Jackson ImmunoResearch Laboratories. Female mice were studied at approximately eight weeks of age. The
Animal Care and Use Committee at Children’s Hospital Boston and Harvard
Medical School approved all animal protocols.
Antibodies and reagents. ␣-GalCer was synthesized by P.B. Savage
(Brigham Young University, Provo, Utah), and it was used as positive control to induce AHR (unpublished data). Neutralizing rat anti–mouse CD1.1
(CD1d) mAb (hybridoma HB323; American Type Culture Collection) was
used as previously described (16). Anti–mouse IL-17A blocking antibody
(clone eBioTC11-18H10.1) and the control rat IgG1k isotype control antibody (eBioscience) were used in the blocking experiments.
ELISA. Supernatants of lung cell suspensions were collected 48 h after
␣-GalCer restimulation (100 ng/ml). Mouse IL-4 and IFN-␥ levels were
measured by ELISA, as previously described (13).
Flow cytometry. Cells were preincubated with anti-Fc␥ blocking mAb
(2.4G2) and washed before staining. Cells were stained with anti–mouse
FITC NK1.1, PE-Texas red–conjugated CD45, PerCPCy5.5-conjugated
CD3, and Alexa Fluor 750–conjugated CD4 mAb (clone RM4-5). iNKT
cells were identified using APC-conjugated TCR␤ (clone H57-597; eBioscience) and PE-conjugated, PBS57-loaded, CD1d-tetramers (with empty
CD1d tetramers always used as control; National Institute of Allergy and
Infectious Disease Major Histocompatibility Complex Tetramer Core Facility,
Atlanta, GA). For intracellular staining, after permeabilization (Cytofix/
Cytoperm kit; BD Biosciences), cells were incubated with FITC-conjugated
JEM VOL. 205, February 18, 2008

IL-4, FITC-conjugated IFN-␥, APC-conjugated IL-10, Alexa Fluor 647–
conjugated IL-17, or the respective isotype control antibodies, as follows:
FITC-conjugated rat IgG1k, APC-conjugated rat IgG2b, or Alexa Fluor
647–conjugated rat IgG2a (eBioscience). Cells were collected on a BD
Canto flow cytometer (BD Biosciences) and analyzed with FlowJo 8.3.3
software (Tree Star, Inc.).
Adoptive transfer of iNKT cells. iNKT cells were purified from splenocytes of wild-type BALB/c or IL-4⫺/⫺/IL-13⫺/⫺ double-knockout mice
using magnetic cell sorting (MACS), as previously described (13). Splenic
iNKT cells were labeled with PE-conjugated CD1d-tetramer, followed by
anti-PE microbeads (Miltenyi Biotec), and then sorted with AutoMACS according to the manufacturer’s instruction. Purity of iNKT cells was >80%.
Purified iNKT cells (106) were adoptively transferred into recipient J␣18⫺/⫺
mice by intravenous injection 1 d before the first exposure to ozone or air.
Ozone-exposure and measurement of airway responsiveness in the
ozone model. Mice were placed awake in individual wire mesh cages inside a stainless steel and Plexiglas exposure chamber and exposed to ozone
(1 ppm) for 3 h. For room air exposure, a separate and identical exposure
chamber was used. Details of the ozone exposure and monitoring have been
previously described (52). Exposure was repeated every other day (days 0, 2,
and 4) to optimize airway inflammation and iNKT cell recruitment into the
BAL fluid over the shortest period of time, and did not induce any weight
changes in the mice (unpublished data). As a positive control for lung mechanics assessment, control mice received one intranasal injection of ␣-GalCer (0.5 μg) the day before the measurement of AHR (unpublished data).
24 h after the last ozone (day 6) or ␣-GalCer exposure, mice were anesthetized
with 50 mg/kg pentobarbital and instrumented for the measurement of
pulmonary mechanics (BUXCO Electronics). Mice were tracheostomized,
intubated, and mechanically ventilated at a tidal volume of 0.2 ml and a frequency of 150 breath/min, as previously described (52). Baseline lung resistance (RL) and responses to aerosolized saline (0.9% NaCl) were measured
first, followed by responses to increasing doses (0.32 to 40 mg/ml) of aerosolized acetyl-␤-methylcholine chloride (methacholine; Sigma-Aldrich). The
three highest values of RL obtained after each dose of methacholine were
averaged to obtain the final values for each dose.
Induction of AHR and measurement of airway responsiveness in
the OVA model. To induce AHR, we sensitized BALB/c mice with 100 μg
of OVA (Sigma-Aldrich) in alum administered i.p. After 8 d, mice were exposed to intranasal antigen (50 μg OVA/d) or normal saline on 3 consecutive
days, as previously described (13). AHR was assessed on day 12. C57BL/6
mice were sensitized with 100 μg of OVA adsorbed to 2 mg of an aqueous
solution of alum i.p. on days 0 and 14, followed by 50 μg of OVA in 50 μl
of PBS administered intranasally on days 14 and 25–27. Control mice received i.p. injection of PBS and intranasal administrations of normal saline.
AHR was assessed on day 28.
BAL fluid. After measurement of AHR and euthanasia, the lungs were lavaged twice with 1 ml of PBS 2% FCS, and the fluid was pooled as previously described (16). For some experiments, total BAL for each mouse or
pooled BAL was stained and analyzed by flow cytometry. BAL iNKT cell
numbers were quantified by multiplying hemacytometer cell counts, excluding red blood cells, by the percentage of iNKT within a cellular gate that
included lymphocytes, monocytes, large epithelial cells, and granulocytes
(by forward scatter and side scatter).
Lung tissue. After measurement of AHR, killing of the mice, and collection of BAL fluids, lungs were perfused with PBS 2% FCS, and portions of
lung tissues were treated with collagenase type 4 (Worthington Biochemical
Corp.). The lymphocyte-enriched fraction was collected at the 50–70%
interface of Percoll gradients (GE Healthcare), and plated for 2 h with BD
GolgiStop (BD Biosciences) before intracellular staining.
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Moreover, the role of iNKT cells in sensing oxidized lipids
may explain the observation that obesity increases the risk of
developing asthma in humans (48) and in mice (49). Thus,
oxidized lipids, which may develop readily in obese individuals or in obese mice, might serve as an important “antigen”
that activates iNKT cells, leading to the development of
AHR and atherosclerotic heart disease.
In summary, we identified novel cellular and molecular
mechanisms (iNKT cells and IL-17) required for the development of AHR induced by repeated ozone exposure. Importantly, because both ozone-induced and allergen-induced
AHR require the presence of iNKT cells, these results
strongly suggest that iNKT cells mediate a common unifying
pathogenic mechanism for diverse forms of asthma. The specific cytokines produced by iNKT cells in ozone- versus
allergen-induced AHR are distinct, which may account for the
different inflammatory cell types that accompany ozone- and
allergen-induced AHR. Thus, ozone-induced AHR is associated with neutrophils and IL-17, whereas allergen-induced
AHR is associated with eosinophils, but primarily with IL-4
and not IL-17. These results suggest that targeting iNKT may
provide an important and effective therapy for diverse and
mixed forms of asthma.
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Statistical tests. Differences between groups with parametric distributions
were analyzed by Student’s t test; otherwise, the Mann-Whitney U test was
used. Significance for all statistical tests was shown in figures for P ≤ 0.05 (*)
and P ≤ 0.01 (**).
Online supplemental material. Airway inflammation was evaluated in BAL
fluid after ozone exposure (Figs. S1 and S2). The online version of this article
is available at http://www.jem.org/cgi/content/full/jem.20071507/DC1.
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